Why is this high-yielding ASX 200 transport stock falling on Thursday?

Investors are bidding down this high-yielding ASX 200 transport stock today. But why?

| More on:
A businesswoman holding a briefcase rests her head against the glass wall of a city building, she's not having a good day.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) transport stock Atlas Arteria Ltd (ASX: ALX) is catching some headwinds today.

Atlas Arteria shares closed yesterday at $5.09. In late afternoon trade on Thursday, they are changing hands for $4.98 apiece, down 2.2%.

For some context, the ASX 200 is down 0.4% at this same time.

Created with Highcharts 11.4.3Atlas Arteria PriceZoom1M3M6MYTD1Y5Y10YALL1 Jan 20246 Nov 2025Zoom ▾Jan '24Apr '24Jul '24Oct '24Jan '25Apr '25Jul '25Oct '25Jan '24Jan '24Jul '24Jul '24Jan '25Jan '25Jul '25Jul '25www.fool.com.au

This underperformance follows the release of Atlas Arteria's half-year financial results for the six months ending June 30 (H1 2024).

Here are the highlights.

Atlas Arteria shares slip on declining profits

  • Revenue of 1.61 billion euros, up 4.4% from H1 2023
  • Total half-year traffic of 12.29 billion, down 0.7% year on year
  • Earnings before interest, taxes, depreciation and amortisation (EBITDA) of 1.08 billion euros, down 2.9% from H1 2023
  • Net profit after tax of 114.2 million euros, down 16% year on year

What else happened with the ASX 200 transport stock over the year?

The ASX 200 transport stock is popular among passive income investors for its juicy dividends, and it didn't disappoint on that front.

Management reaffirmed full-year dividend guidance of 40 cents per share.

Although profits were down 6.7%, net corporate free cash flow was up 12.7% compared to H1 2023.

The company reported 3.8% year-on-year growth in its proportionate toll revenue, noting that CPI-linked toll increases offset the weighted average traffic reduction, which was down 0.4% year on year. That dip was said to be primarily due to farmers' strikes impacting its APRR motorway network in France.

Speaking of France, the company reported that its legal challenge to the new French long-distance transportation infrastructure tax was ongoing.

The half-year also saw Hugh Wehby appointed as incoming CEO and managing director. Wehby will take over the reins in late 2024.

What did management say?

Commenting on the results pressuring the ASX 200 transport stock today, outgoing Atlas Arteria CEO Graeme Bevans said:

Atlas Arteria delivered strong revenue growth, driven by CPI-linked toll increases, and implemented capital management initiatives that will enhance Atlas Arteria's free cash flow.

We reaffirm 2024 distribution guidance of 40.0 cps and expect a reduction in the use of cash on hand for distribution funding to 4-5 cps compared to previous guidance of 7-8 cps.

Bevans added:

In March, APRR along with the other toll road companies filed a constitutional challenge to the new long-distance transportation infrastructure tax. A decision is expected on 12 September. If we are not successful, APRR will pursue litigation to seek compensation.

In North America, the Chicago Skyway business plan is on track, and we strengthened Atlas Arteria's executive team by hiring Amanda Baxter as group executive for North America and corporate development.

At Dulles Greenway, our objective remains to lower tolls for customers by implementing distance-based tolling, while ensuring the business is on a sustainable financial path.

How has the ASX 200 transport stock been tracking?

With today's slip in the Atlas Arteria share price factored in, the ASX 200 transport stock is down 18% in 12 months.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Neuren Pharmaceuticals Q3 2025: Record DAYBUE sales fuel robust growth

Neuren Pharmaceuticals reported record DAYBUE sales and royalties in Q3 2025, with expanding US and international demand.

Read more »

Management presents the ASX company earnings report to shareholders at an AGM.
Earnings Results

Vicinity Centres FY25 earnings: profit doubles, outlook upbeat

Vicinity Centres reported $1 billion statutory profit for FY25, rising distributions, and a positive outlook for FY26.

Read more »

Happy couple at Bank ATM machine.
Bank Shares

NAB shares fall on FY25 profit miss

Let's see how the banking giant performed during the financial year.

Read more »

Man sitting at poker machine celebrates a win by raising his arms straight up in the air.
Earnings Results

Light & Wonder Q3 earnings: Net income jumps 78%

Light & Wonder reported robust Q3 earnings, with net income up 78% and continued digital segment growth.

Read more »

A woman wearing a yellow shirt smiles as she checks her phone.
Earnings Results

NAB FY25 earnings: Cash earnings steady, dividend rises

NAB delivered flat FY25 cash earnings, a modestly higher dividend, and strong deposit growth while investing in customer experience and…

Read more »

Three smiling people shake hands to seal the deal.
Earnings Results

Westpac shares fall despite reporting $6.9bn profit and dividend increase

Australia's oldest bank has released its full year results this morning. Let's see how it performed.

Read more »

A man wakes up happy with a smile on his face and arms outstretched.
Healthcare Shares

ResMed shares charge higher on strong Q1 update

This sleep disorder treatment company delivered more strong growth during the three months.

Read more »

Woman using a pen on a digital stock market chart in an office.
Earnings Results

ASX Ltd holds AGM: posts earnings growth and outlines FY26 expense guidance

ASX Ltd reported improved revenue and profits and outlined its investment and expense guidance for FY26.

Read more »